{
    "organizations": [],
    "uuid": "949ab4fc6b0a952b6840a68cf8c7cad073b96c0d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-chr-hansen-holding-partners-with-p/brief-chr-hansen-holding-partners-with-prota-therapeutics-idUSFWN1RV04Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Chr Hansen Holding Partners With Prota Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - CHR HANSEN HOLDING A/S:\n* HOLDING A/S - NEW PARTNERSHIP TO DEVELOP TREATMENT FOR PEANUT ALLERGIES\n* PROTA THERAPEUTICS, DEVELOPER OF ORAL IMMUNOTHERAPIES TO TREAT FOOD ALLERGIES, HAS PARTNERED WITH CHR. HANSEN Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-18T15:45:00.000+03:00",
    "crawled": "2018-04-19T14:57:54.047+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "chr",
        "hansen",
        "holding",
        "holding",
        "new",
        "partnership",
        "develop",
        "treatment",
        "peanut",
        "allergy",
        "prota",
        "therapeutic",
        "developer",
        "oral",
        "immunotherapy",
        "treat",
        "food",
        "allergy",
        "partnered",
        "chr",
        "hansen",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}